Hey Geo, how's in hangin' these days? What do you have your hands in bio-wise besides our lifeless XCHO stock?
I'm looking at HEP and IMUC right now - HEP apparently finally satisfied the FDA over their CRL issues, Adcom is Dec 20 and PDUFA Feb 2013 - could be the first drug for CFS ever approved, which could be huge, but Ampligen has a pretty tattered history, makes me a bit leery of buying even a little as a spec play. Would love to try it if approved for *my* CSF problems, but it's so frigging expensive there's no way I could afford it - $2k/month!